TECH OUTLOOK 6MAY - 2022TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comTechnology is critical in drug development. It is transforming clinical trials and lowering failure rates. However, the uncertainty surrounding emerging technologies is causing slow adoption and fragmented supply. To address this, pharmaceutical companies will increasingly use AI and big data analytics to transform their R&D processes. Wearables, mHealth, and RWE are examples of disruptive technologies that will pave the way for smaller trials. Smartphones will be used for patient enrollment, drug administration, and follow-ups. Siteless trials will also enter the clinical trials space via remote applications, reducing patient enrolment time and increasing the diversity of patients and clinical endpoints. Given all of the technological trends that are entering the sector, organizations will need to equip themselves with the most up-to-date clinical trial management solutions in order to meet the evolving requirements.With significant changes sweeping the pharma industry, there is no doubt that clinical trial management is on the fast track of evolution. Standing at the cusp of clinical trial management technology, there is a wide range of solution providers that are addressing the next generation of clinical trial needs. To help clients steer through the best-of-breed companies, Pharma Tech Outlook APAC has compiled a list of Top 10 Clinical Trials Solutions Providers in APAC 2022, Top 10 Clinical Trials Services Companies in APAC 2022. These organizations are transforming the remote work landscape at the cloverleaf of various disruptive technologies and innovative services. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the clinical trial management sector on the latest industry trends, best practices, recent innovations, and highlights their expertise.Let us know your thoughts!Accelerating Clinical Trials through Technology Copyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 18 - 2022, Vol 08 - Issue 03 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, TECH OUTLOOK
< Page 5 | Page 7 >